Evidence map›Paper›PMID 26275495›Full record

ArticleBiochimica et biophysica acta2015

Prooxidant and antioxidant properties of salicylaldehyde isonicotinoyl hydrazone iron chelators in HepG2 cells.

Andres A Caro, Ava Commissariat, Caroline Dunn, Hyunjoo Kim, Salvador Lorente García, Allen Smith, Harrison Strang, Jake Stuppy, Linda P Desrochers, Thomas E Goodwin

Abstract read
In one paragraph

Article in Biochimica et biophysica acta, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Potential Treatment of Retinal Diseases with Iron Chelators.Pharmaceuticals (Basel, Switzerland) · 2018
    Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Andres A CaroChemistry Department, Hendrix College, Conway, AR 72032, USA. Electronic address: caro@hendrix.edu.
Ava CommissariatChemistry Department, Hendrix College, Conway, AR 72032, USA.
Caroline DunnChemistry Department, Hendrix College, Conway, AR 72032, USA.
Hyunjoo KimChemistry Department, Hendrix College, Conway, AR 72032, USA.
Salvador Lorente GarcíaChemistry Department, Hendrix College, Conway, AR 72032, USA.
Allen SmithChemistry Department, Hendrix College, Conway, AR 72032, USA.
Harrison StrangChemistry Department, Hendrix College, Conway, AR 72032, USA.
Jake StuppyChemistry Department, Hendrix College, Conway, AR 72032, USA.
Linda P DesrochersChemistry Department, Hendrix College, Conway, AR 72032, USA.
Thomas E GoodwinChemistry Department, Hendrix College, Conway, AR 72032, USA.
Hendrix College · US

Funding

Understanding Hesitant AdoptersP20GM103429 · NIGMS · UNIV OF ARKANSAS FOR MED SCIS · PI Lawrence E Cornett, JERRY WARE · 2012 to 2026
$60.9M
VIRULENCE MECHANISMS IN ESCHERICHIA COLIP20RR016460 · NCRR · UNIV OF ARKANSAS FOR MED SCIS · PI HENSLEY, LORI · 2001 to 2011
$33.1M
NCRR NIH HHS 5P20RR016460 -11NCRR NIH HHS P20 RR016460NIGMS NIH HHS 8 P20 GM103429-11NIGMS NIH HHS P20 GM103429
6 · The paper itself

Abstract

backgroundSalicylaldehyde isonicotinoyl hydrazone (SIH) is an iron chelator of the aroylhydrazone class that displays antioxidant or prooxidant effects in different mammalian cell lines. Because the liver is the major site of iron storage, elucidating the effect of SIH on hepatic oxidative metabolism is critical for designing effective hepatic antioxidant therapies.

methodsHepatocyte-like HepG2 cells were exposed to SIH or to analogs showing greater stability, such as N'-[1-(2-Hydroxyphenyl)ethyliden]isonicotinoyl hydrazide (HAPI), or devoid of iron chelating properties, such as benzaldehyde isonicotinoyl hydrazone (BIH), and toxicity, oxidative stress and antioxidant (glutathione) metabolism were evaluated.

resultsAutoxidation of Fe(2+)in vitro increased in the presence of SIH or HAPI (but not BIH), an effect partially blocked by Fe(2+) chelation. Incubation of HepG2 cells with SIH or HAPI (but not BIH) was non-toxic and increased reactive oxygen species (ROS) levels, activated the transcription factor Nrf2, induced the catalytic subunit of γ-glutamate cysteine ligase (Gclc), and increased glutathione concentration. Fe(2+) chelation decreased ROS and inhibited Nrf2 activation, and Nrf2 knock-down inhibited the induction of Gclc in the presence of HAPI. Inhibition of γ-glutamate cysteine ligase enzymatic activity inhibited the increase in glutathione caused by HAPI, and increased oxidative stress.

conclusionsSIH iron chelators display both prooxidant (increasing the autoxidation rate of Fe(2+)) and antioxidant (activating Nrf2 signaling) effects. GENERAL SIGNIFICANCE: Activation by SIH iron chelators of a hormetic antioxidant response contributes to their antioxidant properties and modulates the anti- and pro-oxidant balance.

Indexed as

AldehydesAntioxidantsGlutathioneHep G2 CellsHumansHydrazonesIron Chelating AgentsNF-E2-Related Factor 2Oxidation-ReductionReactive Oxygen SpeciesAldehydesAntioxidantsGlutathioneHydrazonesIron Chelating AgentsNFE2L2 protein, humanNF-E2-Related Factor 2Reactive Oxygen Speciessalicylaldehyde isonicotinoyl hydrazoneAntioxidantGlutathioneIronNrf2Oxidative stressSalicylaldehyde isonicotinoyl hydrazone

Identifiers

PMID26275495
PMCPMC4587295
OpenAlexW2195439889

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.